Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson’s Drug But Q1 Earnings Are Mixed

All NewsMay 2, 2025

Amneal Pharmaceuticals reported first-quarter 2025 adjusted earnings per share of 21 cents, up from 14 cents a year ago.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson’s Drug But Q1 Earnings Are Mixed

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Americans’ retirement savings face a hidden drain

BofA lifts Supermicro target despite AI margin concerns

‘The money didn’t work’: Big Tech’s $600mn midterm campaign falls flat

Japan services PMI edges up to 51.7, but composite slips to five-month low as hiring slows

Australia’s trade surplus jumps to A$2.8 billion, a seven-month high, on LNG and metals